Details
Category: Volume 06 Issue 07 July 2018
Hits: 1513

Title: Wrath of Hepatitis C in Jammu: A Hospital Based Population Study

Authors: Dr Shashi S Sharma, Dr Konika Razdan, Ajay Kumar, Suboor Ahmad Naik, Dr Gurmeet Kaur

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i7.112

Abstract

Background and Objective: Currently, India harbors an anticipated 10-15 million chronic carriers of HCV whereas reported prevalence rates vary broadly from 0.09% to 2.02% (Mukhopadhyaya, 2008). Although various studies for seroprevalance are there but still a paucity of data from large multi-centric studies in India remains. The main aim of this study was to estimate the seroprevalance of HCV in the district of Jammu (J&K); as very scarce data regarding the prevalence of HCV in the state of J&K is present.

Methodology: The present study was conducted from January 2014 to December 2016 amongst the patients attending various departments of GMC, Jammu and were referred by them to Viral Research and Diagnostic Lab., Deptt. of Microbiology for anti-Hepatitis C Virus ELISA. The serum was separated for the qualitative detection of HCV antibody by ELISA.

Results: During this study a seroprevalence of 1.158% was determined. Among 235 positive samples 170 (72.34%) were males and 65 (27.65%) were females with an overall seropositivity of 0.83% and 0.32% indicating a male preporederance. The maximum number of HCV positive patients were in the age group of 41-60 (53.24) followed by 18-40 years (31.01%) and 61-80 years (15.74%) and above 80 years none was reported. Among the samples screened 755 (3.72%) were from HIV care and 6 among which was found to be positive (0.79%).

Conclusion: Control of HCV infection requires a comprehensive approach that incorporates primary prevention of transmission through enhanced infection control and injection safety in healthcare settings and in the community, universal screening of blood and blood products, harm reduction programs, and increased public awareness about risk factors for HCV infection.

References

  1. http://www.who.int
  2. Dore GJ, Freeman AJ, Law M, Kaldor JM. “Is severe liver disease a common outcome for people with chronic hepatitis C?” J Gastroenterol Hepatol. 2002; 17: 423–430.
  1. World Health Organization. Hepatitis C, WHO fact sheet No. 164, updated July 2015. Available from: http://www.who.int/mediacentre/factsheets/fs164_apr2014/en/).
  1. Lingala S, Ghany MG. Natural History of Hepatitis C. Gastroenterol Clin North Am. 2015;44:717–734.
  2. Saito T, Ueno Y. Transmission of hepatitis C virus: self-limiting hepatitis or chronic hepatitis? World J Gastroenterol 2013; 19: 6957-6961).
  3. Carrozzo M, Scally K. Oral manifestations of hepatitis C virus infection. World J Gastroenterol 2014; 20: 7534-7543.
  4. Ozkok A, Yildiz A. Hepatitis C virus associated glomerulopathies. World J Gastroenterol 2014; 20: 7544-7554
  5. Cacoub P, Comarmond C, Domont F, Savey L, Desbois AC, Saadoun D. Extrahepatic manifestations of chronic hepatitis C virus infection. Ther Adv Infect Dis. 2016; 3:3–14).
  6. Petta S, Maida M, Macaluso FS, Barbara M, Licata A, Craxì A, Cammà C. Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies. Gastroenterology. 2016;150:145–155
  7. Lindenbach BD, et al. 2007. Flaviviridae: the viruses and their replication, p 1101–1152. In Knipe DM, Howley, PM (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
  8. Lavie M, Goffard A and Dubuisson J (2007). Assembly of a functional glycoprotein heterodimer. Curr Issues Mol Biol 9: 71-86.
  9. Gower E, Estes C, Blach S, razavi- Shearer K, Razavi H (2014) Global epidemiology      and genotype distribution of the hepatitis C virus infection. Journal of hepatology 61: 45-57.
  10.  Zein NN: Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 2000;13:223-235.
  11. Akkarathamrongsin S, Praianantathavorn K, Hacharoen N, Theamboonlers A, Tangkijvanich P, Tanaka Y, Mizokami M, Poovorawan Y: Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand. J Med Virol 2010;82:257-262.
  12. Khan A, Tanaka Y, Azam Z, Abbas Z, Kurbanov F, Saleem U, Hamid S, Jafri W, Mizokami and relation to high incidence ofhepatocellular carcinoma in Pakistan. J Med Virol 2009; 81:1189-1197
  13. Romano KP, Ali A, Aydin C, Soumana D, O¨ zen A, et al. (2012) The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors. PLoS Pathog 8(7): e1002832. doi:10.1371/journal.ppat.1002832
  14. Shustov AV, Kochneva GV, Sivolobova GF, Grazhdantseva AA, Gavrilova IV, Akinfeeva LA, Rakova IG, Aleshina MV, Bukin VN, Orlovsky VG, Bespalov VS, Robertson BH, Netesov SV: Molecular epidemiology of the hepatitis C virus in western Siberia. J Med Virol 2005;77:382-389
  15. Mukhopadhya A. Hepatitis C in India. J. Biosci. 33(4), November 2008, 465–473.
  16. Shah NA,  Showkat A,  Kadla JS, Khan BA, Shah AI, Sheikh SA,  Rather MK,  Pathania R. A Study on Prevalence of Hepatitis C Among Adult Population in South Kashmir 2017 Volume 7, Supplement 2, Pages S20–S21
  17. Malik S, Sharma PR, Verma UK, Khajuria A, Wani MA, Sharma BB. Seroprevalence of Hepatitis B in healthy blood donors at a teaching hospital of Jammu region.  JK-Practitioner 2011;16(1-2):17-19
  18. Global Surveillance and Control of Hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, antwerp, Belgium. J Viral Hepatol 1999; 6: 35e47.
  19. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13: 2436e2441
  20. Kamal SM. Acute hepatitis C: a systematic review. Am J Gastroenterol 2008; 103: 1283e1297
  21. Gacche RN and Al-Mohani SK. Seroprevalence and Risk Factors for Hepatitis C Virus Infection among General Population in Central Region of Yemen. Hepatitis Research and Treatment Volume 2012, Article ID 689726.
  22. S Mishra, N Chayani, G Sarangi, B Mallick, SB Pati. Seroprevalence of anti HCV antibody in and around Cuttack, Orissa 2002  Volume : 20  Issue : 1  Page : 40-41
  23. Sachdeva S, Mehta B. Population-based hepatitis C survey in a rural block. N Am J Med Sci. 2012; 4(11):591–592
  24. The Current Seroprevalence of Hepatitis C Virus in a Tertiary Care Centre in Vellore, Tamil Nadu. V Gowri, C Chandra-leka, and R Vanaja. Indian J Community Med. 2012 Apr-Jun; 37(2): 137
  25. Patil SR, Datkhile KD, Ghorpade MV, Patil SS, Kakade SV. Seroprevalence, risk factors and genotype distribution for Hepatitis C infection: A study from rural hospital in Maharashtra. Indian J Med Microbiol 2017;35:563-7.
  26. Sood S, Malvankar S. Seroprevalence of hepatitis B surface antigen, antibodies to the hepatitis C virus, and human immunodeficiency virus in a hospital‑ based population in Jaipur, Rajasthan. Indian J Community Med 2010;35:165‑9.
  1. Roche R, Leslie AS, Nayak R. Prevalence of the Human Immunodeficiency Virus, the Hepatitis B and Hepatitis C among the patients at a tertiary health care center: A five year study. Journal of Clinical and Diagnostic Research. 2012;6:623-6.)
  2. Phukan AC, Das HK, Mahanta J(2001)HCV activity in an isolated community in north east India. Indian J Pathol Microbiol 44:403–405.
  3. Chandra M, Khaja MN, Farees N, et al. Prevalence, risk factors and genotype distribution of HCV and HBV infection in the tribal population: a community based study in south India. Trop Gastroenterol. 2003; 24(4):193–195)
  1. Bhattacharya S, Badrinath S, Hamide A, Sujatha S. Seroprevalence of hepatitis C virus in a hospital based general population in South India. Indian J Med Microbiol 2003;21:43-5
  2. Sy T and Mazen Jamal M. 2006. “Epidemiology of hepatitis C virus (HCV) infection,” Int. J. Med. Sci., vol. 3, no. 2, pp. 41– 46, 2006
  3. Iqbal M. An update on the management of hepatitis‑C. J Coll Physicians Surg Pak 2003;13:477‑82
  4. Schwarz TF, Dobler G, Gilch S, Jäger G. Hepatitis C and arboviral antibodies in the Island populations of Mauritius and Rodrigues. J Med Virol 1994;44:379‑83)
  5. Frommel D, Tekle‑Haimanot R, Berhe N, Aussel L, Verdier M, Preux PM, et al. A survey of antibodies to HCV in Ethiopia. Am J Trop Med Hyg 1993;49:435‑9.
  1. Sharma R, Sinha P, Bachiwal R, Rishi S. Seroprevalence of anti‑hepatitis C virus antibodies in a hospital based population in Jaipur, Rajasthan. Indian J Community Med 2007;32:158‑9; Seroprevalence of Hepatitis C Virus in a Tertiary Care Centre in Vijaypur, Karnataka, India.
  2. Paramdeep Singh, Rupinderjeet Kaur, and Amarpreet Kaur Frequency distribution of Hepatitis C virus in different geographical regions of Punjab: Retrospective study from a tertiary care centre in North India. J Nat Sc Biol Med 2014; 5:56-58
  3. Mindolli PB and. Salmani MP J. Curr. Microbiol. App.Sci (2015) 4(10): 956-959
  4. Sandhu R , Dahiya S , Singh B , Aggarwal R , Sharma G.  Outcome of routine testing for HCV and HBV in patients attending and admitted in various surgical units of a tertiary care institute. International Journal of Medical Research and Review. 2016:4(1).
  5. Alsamarai Mohd.AG, Abdulrazaq G and Alobaidi AH. Seroprevelance of Hepatitis C virus in Iraqi population. Juniper online J of Immunovirology. 2016;1 (3).
  6. Kong F, Pan Y, Chi X, Wang X, Chen L, Lv J, Sun H, Wu R, Jinglan Jin, Ge Yu, Zhenhua Ma, Yang Wang, Xinxing Huang, Hua Li, Yang Bai, Jing Jia, Gerald Y. Minuk, Jin Zhong, Bing Sun, Jing Jiang and Junqi Niu. Factors Associated with Spontaneous Clearance of Hepatitis C Virus in Chinese Population. Biomed Res 1nt 2014: 2014: 527030
  7. Fan C, Wei L, Jiang D, et al. Spontaneous viral clearance after 6–21 years of hepatitis B and C viruses coinfection in high HBV endemic area. World Journal of Gastroenterology. 2003;9(9):2012–2016
  8. Chowdhury A, Santra A, Chaudhuri S, Dhali G K, Chaudhuri S,Maity S G, Naik T N, Bhattacharya S K and Mazumder D N. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 2003; 37:802– 809.
  9. Saravanan S, Velu V, Kumarasamy N, Nandakumar S, Murugavel K G, Balakrishnan P, Suniti S and Thyagarajan S P 2007 Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India; World J. Gastroenterol. 13 5015–5020
  10. Tripathi A K, Khanna M, Gupta N and Chandra M 2007 Lowprevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodefi ciency virus in Northern India; J. Assoc. Physicians India 55 429–431
  11. Devi Kh S, Brajachand N, Singh H L and Singh Y M 2005 Coinfection by human immuno defi ciency virus, hepatitis B and hepatitis C virus in injecting drug users; J. Commun. Dis. 37 73–77
  12. Cohen J 2007 HIV/AIDS. India slashes estimate of HIV-infected people; Science 317 179–181

Corresponding Author

Dr Shashi S Sharma, Professor

PI and Nodal Officer, Dept. of Microbiology, GMC Jammu, India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.